Global Nerve Repair and Regeneration Devices Market Growth (Status and Outlook) 2024-2030
Nerve repair, also known as neuroregeneration, is defined as the repair or regrowth of nervous tissues, and cells through the generation of new neurons, axons, synapses, and myelin.
Nerve repair and regeneration offers products such as neurostimulation, neuromodulator, and biomaterial devices.
These devices are used to treat traumatic or neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, and multiple system atrophy.
The global Nerve Repair and Regeneration Devices market size is projected to grow from US$ 6956 million in 2024 to US$ 10350 million in 2030; it is expected to grow at a CAGR of 6.8% from 2024 to 2030.
Segmentation by Type:
- Biomaterials
- Neuromodulation Surgery Devices
Segmentation by Application:
- Stem Cell Therapy
- Neuromodulation Surgery
- Direct Neuropathy
- Nerve Grafting
- Others
Market by Region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
Companies coverage:
- Abbott Laboratories
- Integra Lifesciences Corporation
- Stryker Corporation
- Polyganics
- Medtronic plc
- Boston Scientific Inc
- OrthoMed, Inc
- Synovis Micro Companies Alliance
- Checkpoint Surgical
- Axogenic
Key Questions Addressed in this Report:
Frequently Asked Questions
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market